Philogen SpA (MIL:PHIL) Short Interest


MIL:PHIL Philogen SpA MIL:PHIL
62 GF Score
Price €23.30
GF Value €227.22
Valuation Possible Value Trap
! 3 Warning Signs
View Full Analysis

What is Philogen SpA Short Interest?

Short Interest can be expressed as a percentage by dividing the number of shares sold short by the total number of outstanding shares.

Due to the license agreement change with our data vendor, Short Interest related data on GuruFocus will no longer be updated. Existing data will remain as-is, while new data will not be available, except for certain Australian and Canadian stocks.

MIL:PHIL vs VRTX, REGN, ALNY: Short Interest Comparison

For the Biotechnology subindustry, Philogen SpA's Short Interest, along with its competitors' market caps and Short Interest data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Philogen SpA Short Interest vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Philogen SpA's Short Interest distribution charts can be found below:

* The bar in red indicates where Philogen SpA's Short Interest falls into.


MIL:PHIL
62GF Score
Philogen SpA MIL:PHIL
Short Interest is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Philogen SpA (MIL:PHIL) Overvalued in 2026?

Based on GuruFocus' analysis, Philogen SpA stock appears to be undervalued. The current stock price of €23.30 is trading 89.7% below its estimated GF Value™ of €227.22. GuruFocus considers Philogen SpA to be Possible Value Trap.

Key valuation signals for MIL:PHIL:

  • Short Interest:
  • GF Value™: €227.22 vs. price of €23.30 (89.7% below fair value)
  • GF Score™: 62/100 with 3 warning signs

No single metric tells the full story. See the MIL:PHIL stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Philogen SpA Business Description

Other Exchanges 78Q:Germany
Address Piazza La Lizza No. 7, Siena, ITA, 53100
Philogen SpA is a biotechnology company engaged in the research and development of antibody-based therapeutics for the treatment of cancer and chronic inflammatory diseases. The company's pipeline includes products such as Nidlegy, Fibromun, Darleukin, and Dekavil, targeting oncology and other serious conditions. Geographically, the company operates in the European Union, Switzerland, and the United States of America.
62GF Score

Get the complete analysis for MIL:PHIL

Short Interest is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€23.30
Price
€227.22
GF Value